Last reviewed · How we verify

NCT05176535: PROSALVAG

Determination of Vaginal Colonization and the Effect of an Oral Probiotic (PROSALVAG)

Completed NA Last updated 4 December 2025
What this trial tests

NA trial testing FertyBiotic Balance in Microbial Colonization in 32 participants. Completed in 28 May 2024.

Timeline
11 October 2021
Primary endpoint
15 January 2024
28 May 2024

Quick facts

Lead sponsorFertypharm
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposesupportive care
Enrollment32
Start date11 October 2021
Primary completion15 January 2024
Estimated completion28 May 2024
Sites1 location across Spain

Drugs / interventions tested

Conditions studied

Sponsor

Fertypharm — full company profile →

Who can join

Adults 35 to 43, female only, with Microbial Colonization or Dysbiosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to determine the efficacy of an oral nutraceutical with probiotics in restore vaginal health.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Microbial Colonization

Currently open trials in the same condition.

Other Fertypharm trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05176535.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing